Cancer drugs: value is about more than cost

Cancer drugs: value is about more than costSue Mahony

When assessing the true value of cancer drugs, collaboration with key stakeholders, reform of the development process and reimbursement system, and a true understanding of what is important to the... Read more

NICE and the 2015 General Election

NICE and the 2015 General ElectionLeela Barham

What could the forthcoming UK General Election in May 2015 mean for the always evolving National Institute for Health and Care Excellence (NICE)? Leela Barham takes a look at how... Read more

Cutting-edge DNA sequencing to speed diagnostics

Cutting-edge DNA sequencing to speed diagnosticsQuah Shun Ying and Syamala Ariyanchira

Next Generation Sequencing (NGS) technologies are allowing scientists to sequence DNA faster and expand knowledge of the genetic basis of disease. NGS is showing particular promise in areas where current... Read more

Social enterprises: doing NHS business without the bureaucracy

Social enterprises: doing NHS business without the bureaucracy Nisha Desai

Nisha Desai, head of medicines management at social enterprise company Provide, speaks to pharmaphorum about how such organisations are benefitting the NHS, prior to her appearance at a major London... Read more